These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3717186)

  • 1. Beta-lactam/aminoglycoside combinations: interactions and their mechanisms.
    Moellering RC; Eliopoulos GM; Allan JD
    Am J Med; 1986 May; 80(5C):30-4. PubMed ID: 3717186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
    DeJace P; Klastersky J
    Am J Med; 1986 Jun; 80(6B):29-38. PubMed ID: 3524218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism at clinically attainable concentrations of aminoglycoside and beta-lactam antibiotics.
    Hooton TM; Blair AD; Turck M; Counts GW
    Antimicrob Agents Chemother; 1984 Oct; 26(4):535-8. PubMed ID: 6517544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concept of empiric therapy with antibiotic combinations. Indications and limits.
    Klastersky J
    Am J Med; 1986 May; 80(5C):2-12. PubMed ID: 3521271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials.
    Marcus R; Paul M; Elphick H; Leibovici L
    Int J Antimicrob Agents; 2011 Jun; 37(6):491-503. PubMed ID: 21292449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative review of combination therapy: 2 beta-lactams versus beta-lactam plus aminoglycoside].
    Dejace P; Klastersky J
    Infection; 1987; 15 Suppl 4():S158-67. PubMed ID: 3312028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside/beta-lactam combinations in clinical practice.
    Leibovici L; Paul M
    J Antimicrob Chemother; 2007 Nov; 60(5):911-2. PubMed ID: 17890282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram.
    Clark RB; Pakiz CB; Hostetter MK
    Med Microbiol Immunol; 1990; 179(2):77-86. PubMed ID: 2113159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal synergism between beta-lactams and aminoglycosides: mechanism and possible therapeutic implications.
    Davis BD
    Rev Infect Dis; 1982; 4(2):237-45. PubMed ID: 7051225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between beta-lactam and other antibiotics.
    Holm SE
    Rev Infect Dis; 1986; 8 Suppl 3():S305-14. PubMed ID: 3529323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Scribner RK; Marks MI; Weber AH; Tarpay MM; Welch DF
    Antimicrob Agents Chemother; 1982 Jun; 21(6):939-43. PubMed ID: 6810757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism and antagonism in double beta-lactam antibiotic combinations.
    Gutmann L; Williamson R; Kitzis MD; Acar JF
    Am J Med; 1986 May; 80(5C):21-9. PubMed ID: 3487247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential risks of treating bacterial infections with a combination of β-lactam and aminoglycoside antibiotics: A systematic quantification of antibiotic interactions in E. coli blood stream infection isolates.
    Fatsis-Kavalopoulos N; Roelofs L; Andersson DI
    EBioMedicine; 2022 Apr; 78():103979. PubMed ID: 35367773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined antibiotic therapy of bacterial infection (review lecture)].
    Kuznetsova SM
    Antibiotiki; 1983 Feb; 28(2):99-117. PubMed ID: 6340599
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergism and antagonism.
    Eliopoulos GM
    Infect Dis Clin North Am; 1989 Sep; 3(3):399-406. PubMed ID: 2671129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro killing activity of combinations of beta-lactam agents with aminoglycosides against penicillin-resistant pneumococci.
    Schlegel L; Sissia G; Fremaux A; Geslin P
    J Antimicrob Chemother; 1997 Jan; 39(1):95-8. PubMed ID: 9044034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.
    Bliziotis IA; Samonis G; Vardakas KZ; Chrysanthopoulou S; Falagas ME
    Clin Infect Dis; 2005 Jul; 41(2):149-58. PubMed ID: 15983909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the clinical implications of β-lactam-aminoglycoside synergism.
    Espino-Hernández M
    Int J Antimicrob Agents; 2011 Aug; 38(2):185-6; author reply 186. PubMed ID: 21621981
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa.
    Meyer RD; Liu S
    Diagn Microbiol Infect Dis; 1988 Nov; 11(3):151-7. PubMed ID: 3149927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis.
    Heffernan AJ; Sime FB; Sun J; Lipman J; Kumar A; Andrews K; Ellwood D; Grimwood K; Roberts J
    Int J Antimicrob Agents; 2020 Mar; 55(3):105839. PubMed ID: 31704215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.